MaastrICCht

Maastricht Intensive Care Covid cohort | collaboration | observational study | serial data | infrastructure | open data | governance | valid | epidemiology

[Iwan van der Horst @iccvanderhorst]

The future is open. The essential steps to create large datasets was studied and led to recommendations and hopefully more knowledge. Thanks to the collaborators! @JipdeKok @BusselBas @MaastrichtU @CARIMMaastricht
https://t.co/1ImoQivuZA

[Bas van Bussel @BusselBas]

Snel, precies, of allebei de volgende keer?

https://t.co/WgStq3JihA

@carim @MaastrichtUMC #data #corona

[BMJ Global Health @GlobalHealthBMJ]

"We recommend the development of a framework to advise concerns of informed consent and other ethics regulations during times of crisis and in situations with limited resources."

@BusselBas @iccvanderhorst @nick_wilmes

📣 New Research ➡️ https://t.co/ZcWiQzw2nj

[MaastrICCht @cht_ic]

Prediction models developed for COVID-19 now externally validated for ICU: Would those have made a difference ? https://t.co/qiPKdKnN6s

[MaastrICCht @cht_ic]

The MaastrICCht collaborators show that SARS-CoV-2 survivors have more favourable EIT-derived parameters and a higher compliance compared to non-survivors over time.
https://t.co/U5AiB3jxXD

@CARIMMaastricht, @CAPHRI_UM, @MaastrichtUMC

[MaastrICCht @cht_ic]

MaastrICCht collaborators show that coronary artery calcifications are associated with more severe multiorgan failure in mechanically ventilated COVID-19 patients. @CARIMMaastricht @cht_ic @CAPHRI_UM @MaastrichtUMC

https://t.co/aDlpVaSmrs

[Anne Raafs @raafs_anne]

Over 35% of survivors of severe #COVID-19 showed #cardiacabnormalities after extensive cardiovascular #follow-up. @cht_ic @MaastrichtUMC @CARIMMaastricht @ChahindaGhoss

https://t.co/gqDh5e28t7

#CMR #echocardiography #coronaryarterydisease #electrocardiography #COVID

[MaastrICCht @cht_ic]

Serial myocardial injury markers in mechanically ventilated Covid-19 patients are associated with mortality, shown by MaastrICCht collaboraties

https://t.co/y3vi0rMP8z

@RobDriessen @MoediGhossein92 @ChahindaGhoss @kvernooy @iccvanderhorst @BusselBas @CARIMMaastricht @CAPHRI_UM

[MaastrICCht @cht_ic]

Cross-boarder Euregio data collaboration shows that women with Covid have better ICU survival

https://t.co/GBhuXvasPc

@iccvanderhorst @ChahindaGhoss @InterregEMR #covid #gender

[Iwan van der Horst @iccvanderhorst]

Trust, cross-border network, one of those things that evolved during the pandemic @CritCareMed @BusselBas @cht_ic @bickenbach_j https://t.co/JGseIkYF4H
https://t.co/XwIv6qR0JC
https://t.co/nmMV6fjY2i

[MaastrICCht @cht_ic]

The MaastrICCht collaborators evaluated hypercoagulability and hypofibrinolysis in critically ill COVID-19 patients 6 months after ICU discharge. #MaastrICCht
https://t.co/Lhbot8ZTUu

[MaastrICCht @cht_ic]

CoDaP project
Maastricht UMC+ (https://t.co/XocDUJwI2h) has started a large-scale study in the CoDaP project to further map the heterogeneity in Covid patients admitted to the intensive care units funded by INTERREG Euregio Meuse-Rhine and EU.
https://t.co/pS52NQ1xzz

[Dutch COVID & Thrombosis Coalition @CovidDutch]

The DCTC has shown that thrombotic complications are more likely to occur in hospitalized COVID-19 patients than in hospitalized patients with influenza. doi: 10.1002/rth2.12496 #RPTH

[MaastrICCht @cht_ic]

MaastrICCht collaborators show that lower concentrations of fibrinogen over time may indicate its consumption related to thrombus formation in the pulmonary vessels in severe Covid-19. #MaastrICCht #MUMC
https://t.co/YNTIOnJpeu

[Frontiers in Cardiovascular Medicine @FrontCVMedicine]

New Research: Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort—Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation: Background: Coronavirus… https://t.co/MJFm2ka7ax #cardiovascular

[MaastrICCht @cht_ic]

The MaastrIccht collaborators show that physical disability, driven by impaired pulmonary function and skeletal muscle quality, is still common in COVID-19 ICU survivors three months following hospital discharge. https://t.co/9xgvOkn0Bv

[MaastrICCht @cht_ic]

The MaastrICCht collaborators propose the use of global coagulation assays to better assess hemostasis in COVID-19 patients. #MaastrICCht https://t.co/f8Qdre39DE

[MaastrICCht @cht_ic]

MaastrICCht collaborators show persistent hypercoagulability and hypofibrinolysis in severe COVID-19 despite anticoagulation. https://t.co/p1CgrN5HkW

[eClinicalMedicine – The Lancet Discovery Science @eClinicalMed]

In this study, Veronique Schiffer, Emma Janssen et al. investigate a priori sex-specific design or post-hoc analyses in #COVID19 trials. 2/5 @MaastrichtU @cht_ic #IWD21

👉 https://t.co/x0ZDoajJ9n

[Laure Wynants @laurewynants.bsky.social @laure_wynants]

A panel consisting of covid-19 survivors, laymen, @BusselBas and I translated the findings of our living review of diagnostic and prognostic models for a general audience. https://t.co/Dxa4yj2BEq